Regulatory Mechanism of MicroRNA Expression in Cancer
- PMID: 32138313
- PMCID: PMC7084905
- DOI: 10.3390/ijms21051723
Regulatory Mechanism of MicroRNA Expression in Cancer
Abstract
Altered gene expression is the primary molecular mechanism responsible for the pathological processes of human diseases, including cancer. MicroRNAs (miRNAs) are virtually involved at the post-transcriptional level and bind to 3' UTR of their target messenger RNA (mRNA) to suppress expression. Dysfunction of miRNAs disturbs expression of oncogenic or tumor-suppressive target genes, which is implicated in cancer pathogenesis. As such, a large number of miRNAs have been found to be downregulated or upregulated in human cancers and to function as oncomiRs or oncosuppressor miRs. Notably, the molecular mechanism underlying the dysregulation of miRNA expression in cancer has been recently uncovered. The genetic deletion or amplification and epigenetic methylation of miRNA genomic loci and the transcription factor-mediated regulation of primary miRNA often alter the landscape of miRNA expression in cancer. Dysregulation of the multiple processing steps in mature miRNA biogenesis can also cause alterations in miRNA expression in cancer. Detailed knowledge of the regulatory mechanism of miRNAs in cancer is essential for understanding its physiological role and the implications of cancer-associated dysfunction and dysregulation. In this review, we elucidate how miRNA expression is deregulated in cancer, paying particular attention to the cancer-associated transcriptional and post-transcriptional factors that execute miRNA programs.
Keywords: cancer; epigenetic modification; genetic alterations; microRNA; microRNA biogenesis; post-transcriptional regulation.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
Exploring Mechanisms of MicroRNA Downregulation in Cancer.Microrna. 2017;6(1):2-16. doi: 10.2174/2211536605666161208154633. Microrna. 2017. PMID: 27928946 Review.
-
MicroRNA: A signature for cancer progression.Biomed Pharmacother. 2021 Jun;138:111528. doi: 10.1016/j.biopha.2021.111528. Epub 2021 Mar 23. Biomed Pharmacother. 2021. PMID: 33770669 Review.
-
Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy.Mol Biol Rep. 2022 Jul;49(7):6827-6846. doi: 10.1007/s11033-021-07040-2. Epub 2022 Jan 15. Mol Biol Rep. 2022. PMID: 35031927 Review.
-
Regulation of microRNA-1 (miR-1) expression in human cancer.Biochim Biophys Acta Gene Regul Mech. 2017 Feb;1860(2):227-232. doi: 10.1016/j.bbagrm.2016.12.004. Epub 2016 Dec 5. Biochim Biophys Acta Gene Regul Mech. 2017. PMID: 27923712 Review.
-
Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcription.BMC Genomics. 2011 Jan 21;12:54. doi: 10.1186/1471-2164-12-54. BMC Genomics. 2011. PMID: 21255435 Free PMC article.
Cited by
-
UBE2R2-AS1, as a prognostic marker of gastric cancer, promotes the malignant phenotype of gastric cancer cells.Histol Histopathol. 2024 Jun;39(6):739-745. doi: 10.14670/HH-18-677. Epub 2023 Nov 21. Histol Histopathol. 2024. PMID: 38009743
-
Barriers in systemic delivery and preclinical testing of synthetic microRNAs in animal models: an experimental study on miR-215-5p mimic.Physiol Res. 2021 Jul 12;70(3):481-487. doi: 10.33549/physiolres.934571. Epub 2021 May 12. Physiol Res. 2021. PMID: 33982582 Free PMC article.
-
Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer.Int J Mol Sci. 2023 Dec 15;24(24):17523. doi: 10.3390/ijms242417523. Int J Mol Sci. 2023. PMID: 38139352 Free PMC article. Review.
-
Human Melanoma Cells Differentially Express RNASEL/RNase-L and miR-146a-5p under Sex Hormonal Stimulation.Curr Issues Mol Biol. 2022 Oct 11;44(10):4790-4802. doi: 10.3390/cimb44100326. Curr Issues Mol Biol. 2022. PMID: 36286041 Free PMC article.
-
Baitouweng decoction suppresses growth of esophageal carcinoma cells through miR-495-3p/BUB1/STAT3 axis.World J Gastrointest Oncol. 2024 Jul 15;16(7):3193-3210. doi: 10.4251/wjgo.v16.i7.3193. World J Gastrointest Oncol. 2024. PMID: 39072160 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials